Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

MiMedx outlines $250M-$260M 2026 net sales as it targets >20% adjusted EBITDA margin with Sanara

We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at seekingalpha.com →

More in Finance & Markets

ABS issuance falls 5.7% in Q3

The issuance of asset-backed securities (ABS) in South Korea declined by more than 5 percent from a year earlier in the third quarter of the year on a decline in property-backed securities, data…

More from Thursday 29 October →